• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AVEO Pharmaceuticals Inc

+ Add to Watchlist

AVEO:US

0.8500 USD 0.0400 4.94%

As of 20:10:00 ET on 12/19/2014.

Snapshot for AVEO Pharmaceuticals Inc (AVEO)

Open: 0.9400 Day's Range: 0.8446 - 0.9482 Volume: 1,155,125
Previous Close: 0.8100 52wk Range: 0.6050 - 2.0700 1-Yr Rtn: -49.70%

Stock Chart for AVEO

No chart data available.
  • AVEO:US 0.8500
  • 1D
  • 1M
  • 1Y
0.8100
Interactive AVEO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AVEO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8525
Est. EPS (USD) (12/2014) -0.9600
Est. PEG Ratio -
Market Cap (M USD) 44.42
Shares Outstanding (M) 52.26
30 Day Average Volume 404,882
Price/Book (mrq) 1.2959
Price/Sale (ttm) 2.3946
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AVEO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AVEO

Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company's lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.

Tuan Ha-NgocPresident/CEO/Acting CFOJeno GyurisChief Scientific Officer
Michael P BaileyChief Business OfficerJoseph VittiglioSenior VP/General Counsel
More Company Profile & Key Executives for AVEO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • AVEO News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil